• Department of Gastroenterology, Suining Central Hospital, Suining, Sichuan 629000, P. R. China;
HE Suyu, Email: hesuyu2009@163.com
Export PDF Favorites Scan Get Citation

Objective  To investigate the gastrin level in patients with type 2 diabetes mellitus (T2DM) with gastroesophageal reflux disease (GERD), and analyze the possible mechanism of gastrin in the pathogenesis of T2DM combined with GERD. Methods  Thirty-eight patients with T2DM combined with GERD treated between January 2013 and January 2015 were designated as group A; 40 patients with T2DM only were regarded as group B; 36 patients with GERD only were regarded as group C; and another 40 healthy volunteers who underwent physical examination at the same period were regarded as group D. The fasting serum levels of gastrin were measured and compared among the above four groups. Results  The fasting serum level of gastrin was significantly higher in group A [(116.53±22.02) pg/mL] than group B [(101.89±20.76) pg/mL], group C [(90.04±21.16) pg/mL], and group D [(92.48±19.69) pg/mL] (P<0.01). The fasting serum level of gastrin in group B was significantly higher than group C and D (P<0.05). There was no significant difference between group C and D in terms of fasting serum level of gastrin (P>0.05). Conclusions  There is a high level of gastrin in patients with GERD combined with T2DM. Abnormal secretion of gastrin may be closely related with the occurrence and development of T2DM and GERD.

Citation: HE Suyu, LIU Yijun, CHEN Yongjun, TANG Yi, XU Jianyu, WU Yan. A study on the level of gastrin in patients with type 2 diabetes mellitus and gastroesophageal reflux disease. West China Medical Journal, 2017, 32(3): 383-386. doi: 10.7507/1002-0179.201601117 Copy

  • Previous Article

  • Next Article

    Survey on the knowledge of primary hospital doctors and diabetes patients on diabetes and exploration on the improvement of diabetes prevention and treatment